Phenominer Database Results (60 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Experiment Notes Record ID Study ID
DA/Bkl post-insult time to onset of experimental arthritis type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 joint integrity trait both 66 days-126 days 105 15.0 d 0.2 2.0 in vivo visual assessment 0.0 immunized 10 days variable 68143 850
BN/SsN percentage of study population developing chronic experimental arthritis during a period of time Freund's incomplete adjuvant (50 %) (between 1 and 7 days) and type II collagen (2 mg/kg) (between 1 and 7 days) then Freund's incomplete adjuvant (50 %) (between 1 and 35 days) and type II collagen (100 ug) (between 1 and 35 days) Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 joint integrity trait male 66 days-126 days 13 0.0 % in vivo visual assessment 0.0 0 69923 1241
BBDR/Rhw calculated serum anti-rat type 2 collagen autoantibody titer Freund's incomplete adjuvant (50 %) and type II collagen (2 mg/kg) Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 blood autoantibody amount female 66 days-126 days 13 31.7 null 1.75 6.3 enzyme linked immunosorbent assay 0.0 0 titer 69926 1241
DA/Bkl percentage of study population developing experimental arthritis during a period of time type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 joint integrity trait both 66 days-126 days 105 100.0 % in vivo visual assessment 0.0 immunized 10 days variable 69959 850
DA.PVG.1AV1-(D4Rat155-Spr) post-insult time to onset of experimental arthritis type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 14 14.3 d 0.3 1.12 in vivo visual assessment 0.0 0 69780 1162
DA/Ztm maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 12 13.4 % 1.4 4.85 body weighing method 0.0 0 69798 1162
DA.PVG.1AV1-(D4Rat155-D4Rat84) percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 14 71.0 % in vivo visual assessment 0.0 0 69711 1162
DA.PVG.1AV1-(D4Rat155-Spr) serum orosomucoid 1 level type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. orosomucoid 1 amount both 120 days-180 days 14 660.0 mg/l radial immunodiffusion assay 0.0 0 radial immunodiffusion assay blood alpha-1-acid glycoprotein amount 69759 1162
DA.PVG.1AV1-(D4Mgh17-D4Rat56) post-insult time to onset of experimental arthritis type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait male 120 days-200 days 13 15.5 d 0.2 0.72 in vivo visual assessment 0.0 0 69783 1162
DA.PVG.1AV1-(D4Rat63-D4Rat203) post-insult time to onset of experimental arthritis type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 10 16.4 d 0.8 2.53 in vivo visual assessment 0.0 0 69791 1162
DA.PVG.1AV1-(D4Rat63-D4Rat203) maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 10 14.6 % 1.8 5.69 body weighing method 0.0 0 69810 1162
DA.F344-(D10Rat204-D10Arb22)/Arb percentage of study population developing experimental arthritis during a period of time type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Joe B, et al., Immunogenetics 2000 Sep;51(11):930-44. joint integrity trait female 63 days-126 days 10 100.0 % in vivo visual assessment 3024000.0 0 70155 1299
F344/NHsd percentage of study population developing experimental arthritis during a period of time type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Joe B, et al., Immunogenetics 2000 Sep;51(11):930-44. joint integrity trait female 63 days-126 days 10 30.0 % in vivo visual assessment 3024000.0 0 70149 1299
BN/SsN percentage of study population developing chronic experimental arthritis during a period of time Freund's incomplete adjuvant (50 %) (between 1 and 7 days) and type II collagen (2 mg/kg) (between 1 and 7 days) then Freund's incomplete adjuvant (50 %) (between 1 and 35 days) and type II collagen (100 ug) (between 1 and 35 days) Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 joint integrity trait female 66 days-126 days 7 0.0 % in vivo visual assessment 0.0 0 69924 1241
BN/SsN percentage of study population developing experimental arthritis during a period of time type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 joint integrity trait both 66 days-126 days 13 0.0 % in vivo visual assessment 0.0 immunized 10 days variable 69961 850
DA/Ztm post-insult time to onset of experimental arthritis type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 10 14.2 d 0.4 1.26 in vivo visual assessment 0.0 0 69790 1162
PVG.1AV1 percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 15 33.0 % in vivo visual assessment 0.0 0 69710 1162
DA/Ztm percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 12 100.0 % in vivo visual assessment 0.0 0 69709 1162
DA/Bkl body weight loss type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 body mass both 66 days-126 days 105 19.0 % 0.49 5.0 body weighing method 0.0 immunized 10 days variable (weight loss) 69960 850
PVG.1AV1 serum orosomucoid 1 level type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. orosomucoid 1 amount both 120 days-180 days 15 250.0 mg/l radial immunodiffusion assay 0.0 0 radial immunodiffusion assay blood alpha-1-acid glycoprotein amount 69757 1162
DA/Bkl percentage of study population developing experimental arthritis during a period of time type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Joe B, et al., Immunogenetics 2000 Sep;51(11):930-44. joint integrity trait female 63 days-126 days 14 100.0 % in vivo visual assessment 3024000.0 0 70147 1299
BN/SsN calculated serum anti-rat type 2 collagen autoantibody titer Freund's incomplete adjuvant (50 %) and type II collagen (2 mg/kg) Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 blood autoantibody amount male 66 days-126 days 13 1.3 null 0.28 1.0 enzyme linked immunosorbent assay 0.0 0 titer 69927 1241
DA.PVG.1AV1-(D4Rat63-D4Rat203) percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 10 100.0 % in vivo visual assessment 0.0 0 69723 1162
DA.PVG.1AV1-(D4Mgh17-D4Rat56) serum orosomucoid 1 level type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. orosomucoid 1 amount both 120 days-180 days 11 540.0 mg/l radial immunodiffusion assay 0.0 0 radial immunodiffusion assay blood alpha-1-acid glycoprotein amount 69760 1162
DA/Ztm serum orosomucoid 1 level type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. orosomucoid 1 amount both 120 days-180 days 12 790.0 mg/l radial immunodiffusion assay 0.0 0 radial immunodiffusion assay blood alpha-1-acid glycoprotein amount 69756 1162
DA/Ztm serum orosomucoid 1 level type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. orosomucoid 1 amount male 120 days-180 days 9 590.0 mg/l radial immunodiffusion assay 0.0 0 radial immunodiffusion assay blood alpha-1-acid glycoprotein amount 69761 1162
DA/Ztm serum orosomucoid 1 level type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. orosomucoid 1 amount both 120 days-180 days 10 600.0 mg/l radial immunodiffusion assay 0.0 0 radial immunodiffusion assay blood alpha-1-acid glycoprotein amount 69769 1162
DA.PVG.1AV1-(D4Rat63-D4Rat203) serum orosomucoid 1 level type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. orosomucoid 1 amount both 120 days-180 days 10 660.0 mg/l radial immunodiffusion assay 0.0 0 radial immunodiffusion assay blood alpha-1-acid glycoprotein amount 69770 1162
DA.PVG.1AV1-(D4Mgh17-D4Rat56) post-insult time to onset of experimental arthritis type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 11 15.4 d 0.5 1.66 in vivo visual assessment 0.0 0 69781 1162
DA.PVG.1AV1-(D4Mgh17-D4Rat56) maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 11 0.7 % 1.6 5.31 body weighing method 0.0 0 69801 1162
DA/Ztm maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 10 22.8 % 1.1 3.48 body weighing method 0.0 0 69809 1162
DA/Ztm percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait male 120 days-200 days 9 100.0 % in vivo visual assessment 0.0 0 69714 1162
DA.PVG.1AV1-(D4Mgh17-D4Rat56) percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait male 120 days-200 days 13 100.0 % in vivo visual assessment 0.0 0 69715 1162
DA.PVG.1AV1-(D4Mgh17-D4Rat56) percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 11 100.0 % in vivo visual assessment 0.0 0 69713 1162
BN/SsN calculated serum anti-rat type 2 collagen autoantibody titer type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 blood autoantibody amount both 66 days-126 days 13 2.0 null 0.55 2.0 enzyme linked immunosorbent assay 0.0 immunized 10 days variable titer 69965 850
DA.PVG.1AV1-(D4Rat155-D4Rat84) post-insult time to onset of experimental arthritis type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 14 17.6 d 0.8 2.99 in vivo visual assessment 0.0 0 69779 1162
BBDR/Rhw percentage of study population developing chronic experimental arthritis during a period of time Freund's incomplete adjuvant (50 %) (between 1 and 7 days) and type II collagen (2 mg/kg) (between 1 and 7 days) then Freund's incomplete adjuvant (50 %) (between 1 and 35 days) and type II collagen (100 ug) (between 1 and 35 days) Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 joint integrity trait female 66 days-126 days 13 100.0 % in vivo visual assessment 0.0 0 69922 1241
DA.F344-(D10Arb20-D10Arb22)/Arb percentage of study population developing experimental arthritis during a period of time type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Joe B, et al., Immunogenetics 2000 Sep;51(11):930-44. joint integrity trait female 63 days-126 days 10 100.0 % in vivo visual assessment 3024000.0 0 70153 1299
DA.F344-(D10Rat204-D10Arb22)/Arb percentage of study population developing experimental arthritis during a period of time type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Joe B, et al., Immunogenetics 2000 Sep;51(11):930-44. joint integrity trait male 63 days-126 days 9 100.0 % in vivo visual assessment 3024000.0 0 70154 1299
BN/SsN body weight loss type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 body mass both 66 days-126 days 13 0.0 % 0.0 0.0 body weighing method 0.0 immunized 10 days variable (weight loss) 69958 850
BN/SsN calculated serum anti-porcine type 2 collagen antibody titer type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 blood immunoglobulin amount both 66 days-126 days 13 3.0 null 0.55 2.0 enzyme linked immunosorbent assay 0.0 immunized 10 days variable titer 69964 850
DA/Bkl calculated serum anti-porcine type 2 collagen antibody titer type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 blood immunoglobulin amount both 66 days-126 days 105 19.0 null 0.59 6.0 enzyme linked immunosorbent assay 0.0 immunized 10 days variable titer 69962 850
DA/Ztm percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 10 100.0 % in vivo visual assessment 0.0 0 69722 1162
DA.PVG.1AV1-(D4Rat155-D4Rat84) serum orosomucoid 1 level type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. orosomucoid 1 amount both 120 days-180 days 14 500.0 mg/l radial immunodiffusion assay 0.0 0 radial immunodiffusion assay blood alpha-1-acid glycoprotein amount 69758 1162
DA/Bkl calculated serum anti-rat type 2 collagen autoantibody titer type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Griffiths MM, et al., Arthritis Rheum 2000 Jun;43(6):1278-89 blood autoantibody amount both 66 days-126 days 105 15.0 null 0.59 6.0 enzyme linked immunosorbent assay 0.0 immunized 10 days variable titer 69963 850
DA.PVG.1AV1-(D4Mgh17-D4Rat56) serum orosomucoid 1 level type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. orosomucoid 1 amount male 120 days-180 days 13 540.0 mg/l radial immunodiffusion assay 0.0 0 radial immunodiffusion assay blood alpha-1-acid glycoprotein amount 69762 1162
DA/Ztm maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass male 120 days-200 days 9 7.5 % 2.1 6.3 body weighing method 0.0 0 69802 1162
DA/Ztm post-insult time to onset of experimental arthritis type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait male 120 days-200 days 9 15.2 d 0.2 0.6 in vivo visual assessment 0.0 0 69782 1162
BBDR/Rhw calculated serum anti-rat type 2 collagen autoantibody titer Freund's incomplete adjuvant (50 %) and type II collagen (2 mg/kg) Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 blood autoantibody amount male 66 days-126 days 11 30.6 null 1.51 5.0 enzyme linked immunosorbent assay 0.0 0 titer 69925 1241
DA/Bkl percentage of study population developing experimental arthritis during a period of time type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Joe B, et al., Immunogenetics 2000 Sep;51(11):930-44. joint integrity trait male 63 days-126 days 15 100.0 % in vivo visual assessment 3024000.0 0 70146 1299
F344/NHsd percentage of study population developing experimental arthritis during a period of time type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Joe B, et al., Immunogenetics 2000 Sep;51(11):930-44. joint integrity trait male 63 days-126 days 10 20.0 % in vivo visual assessment 3024000.0 0 70148 1299
BBDR/Rhw percentage of study population developing chronic experimental arthritis during a period of time Freund's incomplete adjuvant (50 %) (between 1 and 7 days) and type II collagen (2 mg/kg) (between 1 and 7 days) then Freund's incomplete adjuvant (50 %) (between 1 and 35 days) and type II collagen (100 ug) (between 1 and 35 days) Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 joint integrity trait male 66 days-126 days 11 100.0 % in vivo visual assessment 0.0 0 69921 1241
BN/SsN calculated serum anti-rat type 2 collagen autoantibody titer Freund's incomplete adjuvant (50 %) and type II collagen (2 mg/kg) Furuya T, et al., Hum Mol Genet 2000 Sep 22;9(15):2241-50 blood autoantibody amount female 66 days-126 days 7 1.9 null 0.68 1.8 enzyme linked immunosorbent assay 0.0 0 titer 69928 1241
DA/Ztm post-insult time to onset of experimental arthritis type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 12 14.5 d 0.5 1.73 in vivo visual assessment 0.0 0 69777 1162
PVG.1AV1 post-insult time to onset of experimental arthritis type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 15 14.6 d 0.4 1.55 in vivo visual assessment 0.0 0 69778 1162
DA.PVG.1AV1-(D4Rat155-Spr) maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 14 12.5 % 0.9 3.37 body weighing method 0.0 0 69800 1162
DA.PVG.1AV1-(D4Mgh17-D4Rat56) maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass male 120 days-200 days 13 6.6 % 1.3 4.69 body weighing method 0.0 0 69803 1162
DA.PVG.1AV1-(D4Rat155-Spr) percentage of study population developing experimental arthritis during a period of time type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. joint integrity trait both 120 days-200 days 14 100.0 % in vivo visual assessment 0.0 0 69712 1162
DA.PVG.1AV1-(D4Rat155-D4Rat84) maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 14 2.8 % 1.0 3.74 body weighing method 0.0 0 69799 1162
DA.F344-(D10Arb20-D10Arb22)/Arb percentage of study population developing experimental arthritis during a period of time type II collagen (2 mg/kg) and Freund's incomplete adjuvant (50 %) Joe B, et al., Immunogenetics 2000 Sep;51(11):930-44. joint integrity trait male 63 days-126 days 10 100.0 % in vivo visual assessment 3024000.0 0 70152 1299